Big Black Friday Sale 65% Discount Offer - Ends in 0d 00h 00m 00s - Coupon code: exams65

ExamsBrite Dumps

Certified Clinical Research Professional (CCRP) Question and Answers

Certified Clinical Research Professional (CCRP)

Last Update Nov 22, 2025
Total Questions : 130

We are offering FREE CCRP SOCRA exam questions. All you do is to just go and sign up. Give your details, prepare CCRP free exam questions and then go for complete pool of Certified Clinical Research Professional (CCRP) test questions that will help you more.

CCRP pdf

CCRP PDF

$36.75  $104.99
CCRP Engine

CCRP Testing Engine

$43.75  $124.99
CCRP PDF + Engine

CCRP PDF + Testing Engine

$57.75  $164.99
Questions 1

Which countries have officially adopted ICH-GCP E6(R2) as a standard, in addition to U.S., EU, Japan, Canada, and Australia?

Options:

A.  

China

B.  

Switzerland

C.  

Brazil

D.  

India

Discussion 0
Questions 2

After completion of a Phase III trial, which document should IRB/IEC retain?

Options:

A.  

Occupations and affiliations of IRB members

B.  

Sponsor/investigator contracts

C.  

Subject enrollment logs

D.  

Investigational product labels

Discussion 0
Questions 3

A subject currently on a clinical trial was hospitalized for 2 days due to a SAE. The subject reported the hospitalization to the investigator at the next study visit. According to the ICH GCP Guideline, when should the investigator report the SAE to the sponsor?

Options:

A.  

Immediately

B.  

Within 7 working days

C.  

Within 10 working days

D.  

Within 15 working days

Discussion 0
Questions 4

On 15 May 2019, a sponsor announced that its investigational compound GHB33IA will not be investigated any further and will not be pursued for a marketing approval. According to the CFR, what is the earliest date when the site may begin to destroy the study records?

Options:

A.  

16 May 2021

B.  

15 May 2022

C.  

16 May 2022

D.  

15 May 2034

Discussion 0
Questions 5

A study will enroll 420 subjects over 3.5 years. What is expected average monthly accrual?

Options:

A.  

9

B.  

10

C.  

11

D.  

19

Discussion 0
Questions 6

Which document was created by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research and summarizes the basic ethical principles and guidelines for the conduct of research involving human subjects?

Options:

A.  

The Nuremberg Code

B.  

The Declaration of Helsinki

C.  

The ICH Guidelines

D.  

The Belmont Report

Discussion 0
Questions 7

A subject was instructed to do a glucose check 4 times a day for 10 days using an investigational glucose meter. The meter requires one new glucose test strip for each test. The subject received the meter along with 45 glucose test strips. How many unused test strips should the subject have after the 10 days?

Options:

A.  

0

B.  

5

C.  

31

D.  

35

Discussion 0
Questions 8

For a Significant Risk device study, an investigator must report within 5 working days which event?

Options:

A.  

Unanticipated adverse effect

B.  

Completion of investigation

C.  

Withdrawal of FDA approval

D.  

Emergency deviation

Discussion 0
Questions 9

An unconscious patient experiencing life-threatening cardiac arrhythmias has been admitted to an emergency room. No FDA-approved treatment is available, and no legal representative is present. The clinical investigator determined that the use of an investigational antiarrhythmic drug is required. In accordance with the CFR, who must certify the investigator's determination?

Options:

A.  

A sub-investigator

B.  

An independent physician

C.  

The sponsor’s study monitor

D.  

The sponsor’s medical monitor

Discussion 0
Questions 10

After the sponsor’s auditor completes the final audit report for a Phase II trial with an investigational new drug, which of the following is responsible for providing the audit certificate to the clinical site?

Options:

A.  

The IRB/IEC

B.  

The regulatory authority

C.  

The Data Safety Monitoring Board

D.  

The sponsor

Discussion 0
Questions 11

A study team is preparing to initiate a Phase II trial for a novel colon cancer therapy. By signing the Form FDA 1572, the investigator is certifying that the investigator has:

Options:

A.  

Read and understood the investigator's brochure

B.  

Completed other relevant research projects

C.  

Confirmed that the site's SOPs are in place

D.  

Obtained malpractice insurance

Discussion 0
Questions 12

A research site was invited to participate in an investigational drug study. Which of the following parties is responsible for determining the risk-benefit ratio at the site?

Options:

A.  

The clinical investigator

B.  

The IRB/IEC

C.  

The site’s legal counsel

D.  

The sponsor

Discussion 0
Questions 13

During an IND study closeout, a monitor discovered remaining investigational product. Which procedures must be followed for disposition?

Options:

A.  

Sponsor’s procedures

B.  

IRB/IEC’s procedures

C.  

Regulatory authority’s procedures

D.  

Dispensing pharmacy’s procedures

Discussion 0
Questions 14

According to the ICH GCP Guidelines, what is the purpose of source documents?

Options:

A.  

To establish diverse subject enrollment

B.  

To validate insurance reimbursement

C.  

To provide a record of subjects’ investigational medical treatment

D.  

To validate reports submitted to the IRB/IEC

Discussion 0
Questions 15

When can the IRB/IEC require that additional information be given to subjects as part of informed consent?

Options:

A.  

At any time, at the discretion of the IRB/IEC

B.  

At any time, but only if the sponsor agrees that the information is essential

C.  

At any time, but only if the investigator agrees that the information is essential

D.  

At any time, but only if the sponsor and investigator agree that the information is essential

Discussion 0
Questions 16

A sponsor received a report from an investigator regarding the investigator's use of an investigational device without having obtained informed consent. The sponsor must submit a copy of the report to the FDA within:

Options:

A.  

1 day

B.  

5 working days

C.  

10 working days

D.  

30 working days

Discussion 0
Questions 17

In accordance with 45 CFR 46, in addition to the Office for Human Research Protections (OHRP), a suspension of IRB/IEC approval must be reported to which of the following?

Options:

A.  

The local hospital's bioethics committee

B.  

The appropriate institutional officials

C.  

The Scientific Review Committee

D.  

The local hospital's medical director

Discussion 0
Questions 18

Sponsor must maintain drug disposition records for how long after marketing approval?

Options:

A.  

1 year

B.  

2 years

C.  

3 years

D.  

5 years

Discussion 0
Questions 19

A research protocol requires patients to complete a patient reported outcome questionnaire in the sponsor's electronic data capture (EDC) system. What is the source data?

Options:

A.  

The EDC record

B.  

The electronic medical record

C.  

A printout of the electronic medical record

D.  

A printout of the EDC record

Discussion 0
Questions 20

According to ICH GCP, an electronic data capture (EDC) system must:

Options:

A.  

Allow for data changes and store audit trails

B.  

Limit remote access

C.  

Limit file sharing

D.  

Allow access across multiple platforms

Discussion 0
Questions 21

An approved investigational device exemption (IDE) permits a device to be:

Options:

A.  

Shipped lawfully for the purpose of conducting a clinical study

B.  

Sold and marketed for profit

C.  

Used on a patient who is not enrolled on a clinical study

D.  

Marketed as a humanitarian device

Discussion 0
Questions 22

In accordance with the ICH GCP Guideline, who is responsible for the accuracy, completeness, legibility, and timeliness of the data reported to the sponsor in the case report forms and in all required reports?

Options:

A.  

The clinical investigator

B.  

The quality control specialist

C.  

The IRB/IEC coordinator

D.  

The contract research organization monitor

Discussion 0
Questions 23

Which document was created as a response to unethical WWII human experiments?

Options:

A.  

Declaration of Helsinki

B.  

Nuremberg Code

C.  

Belmont Report

D.  

Food, Drug, and Cosmetic Act

Discussion 0
Questions 24

In accordance with 21 CFR Part 11, in order for an electronic record to be equivalent to a paper record the electronic record must be:

Options:

A.  

Printed, signed, and dated

B.  

Managed within a validated computer system

C.  

Entered into an electronic case report form

D.  

Restricted to authorized clinical trial personnel

Discussion 0
Questions 25

In accordance with ICH, which of the following is an acceptable protocol review frequency for an IRB?

Options:

A.  

6 months

B.  

12 months

C.  

24 months

D.  

36 months

Discussion 0
Questions 26

When can an IRB/IEC review a study using expedited review?

Options:

A.  

For initial review of Phase III IND protocol

B.  

For initial review of a study using specimens with identifiers

C.  

For protocol changes involving more than minimal risk

D.  

For minor changes to previously approved protocol

Discussion 0
Questions 27

Which of the following should a clinical investigator include in a submission to an IRB/IEC for a Phase IV drug study?

Options:

A.  

The itemized study budget

B.  

The amount of payments and compensation to subjects

C.  

The drug development and marketing plan

D.  

The investigator's clinical trial agreement with the sponsor

Discussion 0
Questions 28

A nonrandomized study of 30 subjects entitled "A study to evaluate the effectiveness of and to determine the common short-term side effects associated with the drug 'PainStop' for the treatment of subjects with chronic arthritis" is an example of a:

Options:

A.  

Phase I

B.  

Phase II

C.  

Phase III

D.  

Phase IV

Discussion 0
Questions 29

In accordance with the CFR, which body must determine that a study meets the criteria for minimal risk?

Options:

A.  

The clinical investigator

B.  

A data safety monitoring board

C.  

The reviewing IRB/IEC

D.  

The medical monitor

Discussion 0
Questions 30

A sponsor-investigator implemented a protocol deviation in a device trial to eliminate an immediate hazard. Before applying this change to all subjects, what must occur?

Options:

A.  

Obtain IRB/IEC approval

B.  

Inform all subjects

C.  

Train sub-investigators

D.  

Document change in study file

Discussion 0
Questions 31

In accordance with 21 CFR Part 11, a closed electronic records system must do all EXCEPT:

Options:

A.  

Maintain accurate records throughout retention

B.  

Generate audit trails

C.  

Customize access rights

D.  

Print a complete paper copy

Discussion 0
Questions 32

Which of the following would be considered an addendum to an investigator's brochure for an unapproved Investigational Product?

Options:

A.  

Revisions to the risk section of the informed consent form

B.  

A Suspected Unexpected Serious Adverse Reaction (SUSAR) report

C.  

A site-specific SAE report

D.  

Product monograph updates

Discussion 0
Questions 33

Which of the following is an example of an additional protection required when conducting research on children?

Options:

A.  

There must be an impartial advocate present during the consent process

B.  

The investigator must obtain age-appropriate assent as determined by the IRB/IEC

C.  

Parents must be present during all procedures

D.  

The study must be approved by a central pediatric IRB

Discussion 0
Questions 34

An investigator discovered a new serious unanticipated adverse device effect. Who must they notify?

Options:

A.  

FDA

B.  

Sponsor

C.  

Research pharmacist

D.  

OHRP

Discussion 0
Questions 35

An investigator received $60,000 equity interest three years after study completion. What is the financial reporting requirement?

Options:

A.  

None

B.  

Report to FDA

C.  

Report to OHRP

D.  

Report to sponsor

Discussion 0
Questions 36

A coordinator for an ongoing industry-sponsored, multi-site Phase II clinical trial is taking an unexpected, long-term medical absence. The trial site retains coordinator services from an external source to support clinical trial activities. According to the ICH GCP Guideline, which of the following is responsible for implementing procedures to ensure the integrity of the clinical trial-related duties?

Options:

A.  

The sponsor

B.  

The investigator/institution

C.  

The IRB/IEC

D.  

The external source

Discussion 0
Questions 37

An investigator received an updated investigator's brochure from the sponsor; the update did not include changes related to subject safety. Which of the following parties, if any, is the investigator required to notify?

Options:

A.  

The IRB/IEC

B.  

The Data Safety Monitoring Board (DSMB)

C.  

The regulatory authority

D.  

No notification is required

Discussion 0
Questions 38

Which case history documents must be at both sponsor and site?

Options:

A.  

Signed informed consent forms

B.  

Medical records

C.  

Case report forms (CRFs)

D.  

Study visit notes

Discussion 0
Questions 39

According to the CFR, when children who are wards of the state are enrolled into a clinical trial, what is required?

Options:

A.  

The IRB/IEC must include a member who advocates for the children

B.  

Each child must have a patient advocate

C.  

Assenting children must self-represent

D.  

The investigator must represent the children

Discussion 0